NPWT OEM Cooperation Case with Shandong Weigao New Life Medical

Shandong Weigao Xinsheng Medical Device Co., Ltd., a subsidiary of Weigao Group, is a professional medical device company specializing in the research, development, production, and marketing of wound repair and care products. It enjoys a high market influence in the domestic and international wound care field.

Leveraging Weigao Group's comprehensive global sales network and international market layout, the company's products are exported to numerous countries and regions, providing professional wound management solutions to medical institutions worldwide.

Challenge

With the continued growth in international market demand for chronic wound management and negative pressure wound therapy (NPWT) products, customers are seeking partners who possess:

independent R&D capabilities, stable production capacity, a comprehensive quality system, and

experience in supplying to the international market.

Simultaneously, the products must meet multiple requirements, including:

stable clinical treatment effects, high product consistency, long-term bulk supply, and compliance with international export requirements.

Solution

Medison leverages its independently developed Negative Pressure Wound Therapy (NPWT) technology platform to provide OEM manufacturing services to its clients.

Key services include:

1. NPWT equipment R&D support
2. Disposable negative pressure wound therapy material R&D
3. Product design optimization
4. Manufacturing
5. Quality control
6. OEM customization services

Products are manufactured in strict accordance with medical device quality management system requirements to meet international export demands.

Service Process

Phase 1: Technical Exchange

Product Requirements Analysis
Technical Parameter Confirmation
OEM Cooperation Plan Development

Phase 2: Product Development

Product Design Optimization
Sample Verification
Performance Testing

Phase 3: Mass Production

Production Planning
Quality Control
Product Delivery

Phase 4: Ongoing Cooperation

Technical Upgrade Support
Product Improvement and Optimization
International Market Supply Guarantee

Difficulty

The project faces the following challenges during implementation:

1. Strict international market regulations
2. High requirements for product quality consistency
3. Large demand for long-term, stable supply
4. High clinical requirements for wound care products

Collaborative support from R&D, production, and quality management systems is needed.

Grades/Results

Through collaboration, Medison's independently developed NPWT product has successfully achieved large-scale production and entered overseas markets via Weigao International's sales channels.

The product's stable performance and reliable quality have earned customer recognition, establishing a long-term and stable cooperative relationship.

The project has effectively enhanced the customer's product competitiveness in the international wound care market, while also validating Medison's R&D innovation and industrialization capabilities in the field of negative pressure wound therapy.

Advantages

Value Created for Clients
**Rapid Access to Mature NPWT Product Solutions**
**Reduced R&D Costs**
**Shortened Product Launch Cycles**
**Ensuring Consistent Product Quality**
**Meeting International Export Demands**
**Receive Continuous Technical Upgrade Support**
**Medison Core Advantages**
**Independent R&D Capabilities**
**Possess NPWT core technologies and product development capabilities**
**Manufacturing Capabilities**
**A production system and cleanroom environment compliant with ISO13485 standards**
**Extensive OEM/ODM Experience**
**Long-term service to domestic and international medical device brand clients**
**International Market Experience**
**Products exported to Europe, the Middle East, Southeast Asia, Africa, and other countries and regions**
**Continuous Innovation Capabilities**
**Over 20 years of focus on chronic wound management and minimally invasive surgical medical devices**